DNA Sequencing

2026 Global Molecular Diagnostics Market--High-Growth Opportunities and Supplier Strategies—92 Countries, Competitive Shares and Profiles, Market Segment Forecasts for 100 Tests, Analyzers and Consumables, Emerging Technologies and Opportunities

Mon, 04 Nov 2019 12:03:24 +0000

The following are the latest Molecular Diagnostics Market research and technology assessment reports that might interest you and your colleagues:

- World Molecular Diagnostic Instrumentation and Reagents for 100 Tests: A 68-Country Market Analysis

- Molecular Diagnostics: US, Europe, Japan—Segment Forecasts for 100 Tests and Supplier Shares by Country

- Molecular Diagnostics Country Reports: Asia-Pacific, Europe, Latin America, Middle East, North America $0.00

Viral Vectors & Plasmid DNA Manufacturing Market Report 2022-2032

Mon, 26 Dec 2022 10:23:08 +0000

The viral vectors and plasmid DNA manufacturing market was valued at US$482.3 million in 2021 and is projected to grow at a CAGR of 18.09% during the forecast period 2022-2032....

$4,740.00

Asia-Pacific DNA Sequencing Market Forecast 2021-2028

Mon, 23 May 2022 15:54:55 +0000

KEY FINDINGS The Asia-Pacific DNA sequencing market is predicted to record a CAGR of 17.58% during the forecast period, 2021-2028. The rising use of DNA sequencing and its surging demand in the healthcare industry are among the primary growth drivers. MARKET INSIGHTS Thailand, Japan, China, Vietnam, Australia & New Zealand, India, Indonesia, South Korea, and Rest of Asia-Pacific, are assessed for the Asia-Pacific DNA sequencing market growth evaluation. In Japan, the increasing R&D and technological advancements in DNA sequencing drive market growth. The research and development expenses increased to 3.26% in 2018 from 3.15% of GDP in 2016, as per the UNESCO Institute for Statistics data. Also, there is increasing competition for DNA sequencing among leading market players in the country. In Thailand, government initiatives promote market growth. For instance, the launch of the Genomics Thailand Initiative in 2019 to sequence genomes of almost 50,000 population, and infrastructure development to harness genomic information. The country established a Thailand Genomics Sequencing Cente...

$1,250.00

Europe DNA Sequencing Market Forecast 2021-2028

Mon, 23 May 2022 15:54:55 +0000

KEY FINDINGS The Europe DNA sequencing market is set to record a CAGR of 17.23% during the forecast period, 2021-2028. The increasing prioritization of DNA sequencing and the biotechnology industry due to technological innovations in the DNA sequencing platforms, cloud computing applications to store DNA sequencing data, data storage & management, etc., drives the market growth. MARKET INSIGHTS The United Kingdom, Italy, Russia, Poland, Belgium, France, Germany, and Rest of Europe are assessed for the Europe DNA sequencing market growth evaluation. In Germany, the growing prevalence of diseases has resulted in increased investments in the medical research and healthcare sectors. Biotechnology companies and pharmaceuticals are investing considerably in personalized medicine, which is majorly dependent on next-generation sequencing. Most academic institutions accommodate such facilities. Moreover, hospitals and healthcare facilities are projected to get more advanced technologies in the next few years. In France, the rising healthcare expenditure and growing incidence of diseases prop...

$1,250.00

North America DNA Sequencing Market Forecast 2021-2028

Mon, 23 May 2022 15:54:55 +0000

KEY FINDINGS The North America DNA sequencing market growth is predicted to progress at a CAGR of 16.83% during the forecast period, 2021-2028. The prevalence of different types of cancer primarily drives the market growth. MARKET INSIGHTS The United States and Canada are evaluated for the North America DNA sequencing market growth analysis. In Canada, the market growth is steady, accredited to growing funds and research projects. TCAG (The Centre for Applied Genomics) offers genomics support and analyses to over 800 scientific investigators from non-government, academic, and government organizations and private-sector research labs globally. It has been a Canadian Science and Technology Platform since 2001. In February 2018, the Canada 150 Sequencing Initiative (CanSeq150) launch resulted in an increased number of research activities and investment from the government for sequencing of 150 genomes of various species. Moreover, Genome Canada, Thermo Fisher Scientific, and Ontario Institute for Cancer Research (OICR) collaborated in September 2019 to develop next-generation sequencin...

$1,250.00

United States DNA Sequencing Market Forecast 2021-2026

Mon, 23 May 2022 15:54:55 +0000

KEY FINDINGS The United States DNA sequencing market is set to register a CAGR of 16.89% during the forecast period, 2021-2026. Technological developments, advanced healthcare infrastructure, and increasing investment in R&D propel market growth in the country. MARKET INSIGHTS In the United States, several programs and initiatives facilitate market growth. For instance, the precision medicine initiative cohort program encourages around 1 million participants to enhance their ability to treat and prevent diseases associated with differences in genetics, environment, and lifestyle. Also, universal newborn screening plans are conducted in the country. As per research studies, within 24-48 hours after birth, few blood drops drawn from newborns are sent to labs to screen for life-threatening disorders. Such genome sequence-based diagnostics and government plans are raising market demands in the US. DNA sequencing has also caused a paradigm shift in proteomic and genomic research. This is attributed to its accuracy and high-throughput technology utilized for varied applications. It is ado...

$900.00

Global DNA Sequencing Market Forecast 2021-2028

Mon, 23 May 2022 15:54:55 +0000

KEY FINDINGS The global DNA sequencing market growth is estimated to progress at a CAGR of 17.05% during the forecast period, 2021-2028. The market growth drivers include prevailing cancer cases, genome mapping programs implementation, increasing need for DNA sequencing in animals & plant reproduction, liquid biopsy applications, and growing R&D in DNA sequencing. MARKET INSIGHTS DNA sequencing helps in determining the nucleotide sequence of deoxyribonucleic acid (DNA). It has caused altering impacts in the genomics and molecular biology sectors. Genome mapping programs are on the rise globally. They increase awareness about NGS (Next-Generation Sequencing) and collect real-time sequences. They are also genetic data repositories for the world population. According to a December 2019 article, the GenomeAsia 100K consortium analyzed the genomes of 1739 people. It represented the vast genetic diversity coverage in Asia. It was launched in 2016 to understand the genome diversity of Asian ethnicities. Hosted by Nanyang Technological University, it is a non-profit consortium. At the same t...

$2,500.00

DNA Sequencing - Market Insights, Competitive Landscape and Market Forecast–2027

Wed, 27 Apr 2022 14:02:44 +0000

DNA Sequencing Market By Products & Services (Instruments, Consumbales, And Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, And Long-Read Sequencing), By Application (Disease Diagnosis, Precision Medicine, And Research), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical Companies, And Academic Institutes), and by geography is estimated to grow at an appreciable CAGR forecast till 2027 owing to rising prevalence of genetic disorders and growing popularity of precision medicine

Global DNA sequencing market was valued at USD 10.70 billion in 2021, growing at a CAGR of 18.02% during the forecast period from 2022 to 2027, in order to reach USD 28.85 billion by 2027. Factors such as rising prevalence of various diseases with genetic causes such as cancers and chromosomal disorders, growing popularity of personalized medicine due to rising demand for targeted therapies, as well as rising technological advancements leading to the development of newer technologies such as third-generation sequencing are estimated to take the DNA sequenci...

$4,750.00

Global Protein Sequencing Market Research Report 2021-2025

Wed, 08 Sep 2021 14:25:28 +0000

Protein sequencing is the practical process of determining the amino acid sequence of all or part of a protein or peptide. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Protein Sequencing Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Protein Sequencing market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025. The report firstly introduced the Protein Sequencing basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions...

$3,200.00

DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H2 2016

Fri, 07 Apr 2017 13:51:23 +0000

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
DNA Gyrase Subunit B (EC 5.99.1.3) Overview 6
Therapeutics Development 7
DNA Gyrase Subunit B (EC 5.99.1.3) - Products under Development by Stage of Development 7
DNA Gyrase Subunit B (EC 5.99.1.3) - Products under Development by Therapy Area 8
DNA Gyrase Subunit B (EC 5.99.1.3) - Products under Development by Indication 9
DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Products Glance 10
Early Stage Products 10
Unknown Stage Products 11
DNA Gyrase Subunit B (EC 5.99.1.3) - Products under Development by Companies 12
DNA Gyrase Subunit B (EC 5.99.1.3) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
Assessment by Route of Administration 16
Assessment by Molecule Type 18
DNA Gyrase Subunit B (EC 5.99.1.3) - Companies Involved in Therapeutics Development 19
Abgentis Ltd 19
AstraZeneca Plc 20
Daiichi Sankyo Company Ltd 2...

$3,500.00